The earliest finding of digoxin toxicity is usually anorexia, nausea, and vomiting. Using the recognize-cues step of clinical judgment, the nurse should treat new gastrointestinal symptoms in a client taking digoxin as an early warning sign, even though they may seem nonspecific. Digoxin increases cardiac contractility and slows atrioventricular conduction, but its narrow therapeutic range makes toxicity more likely when renal function declines or electrolyte disturbances occur. The key clinical pearl is: a client taking digoxin who suddenly stops eating or develops nausea needs toxicity assessment. Yellow-green halos are strongly associated with digoxin toxicity, but they are generally a later and less early cue than gastrointestinal symptoms.

The correct action is to administer potassium chloride IV using an electronic infusion pump over 2 hours. This follows the Safety and Risk Reduction framework because potassium chloride is a high-alert medication that can cause fatal harm if infused too rapidly. Potassium strongly affects myocardial electrical conduction; rapid IV administration can abruptly raise serum potassium and trigger lethal dysrhythmias or cardiac arrest. A key NCLEX safety rule is that IV potassium is never given by IV push and should not be added to a hanging IV bag. The most tempting distractor is diluting it in a small syringe and pushing it slowly, but a small-volume dilution still delivers potassium as a bolus and remains unsafe.

The nurse should administer the warfarin and continue the heparin infusion because overlap therapy prevents a gap in anticoagulation during treatment of acute DVT. Using the Nursing Process, the nurse implements the prescribed bridge while recognizing that heparin acts immediately and warfarin has a delayed therapeutic effect. Warfarin inhibits synthesis of vitamin K-dependent clotting factors, but existing clotting factors must clear before the INR reaches the target range. A key clinical pearl is that heparin is continued until therapeutic anticoagulation with warfarin is established, commonly reflected by a therapeutic INR for DVT treatment. The tempting action of stopping heparin is unsafe because it can leave the client under-anticoagulated and increase the risk for clot propagation or pulmonary embolism.

The best response is to explain that a persistent dry cough is an expected adverse effect of an ACE inhibitor and notify the provider to discuss alternative therapy. Using the Nursing Process, the nurse first recognizes the cough as medication-related, then takes the appropriate action by communicating with the prescriber rather than independently changing therapy. ACE inhibitors block conversion of angiotensin I to angiotensin II and also reduce breakdown of bradykinin; bradykinin accumulation can irritate the airway and cause a chronic dry cough. The key warning sign is angioedema, especially swelling of the lips, tongue, face, or throat, which is an emergency. The tempting choice to use cough syrup is incorrect because it does not address the pharmacologic cause and may delay medication adjustment.

The nurse should teach the client to use albuterol first, wait about 5 minutes, and then use fluticasone. This medication-administration decision supports the ABC framework because the bronchodilator promotes airway opening before the anti-inflammatory medication is inhaled. Albuterol is a short-acting beta₂-agonist that relaxes bronchial smooth muscle, while fluticasone is an inhaled corticosteroid that reduces airway inflammation but does not provide immediate relief. The key clinical pearl is that inhaled corticosteroids require mouth rinsing after use to reduce the risk for oral candidiasis and dysphonia. The most tempting distractor is using fluticasone first, but that reverses the therapeutic sequence when both inhalers are taken together.

The correct action is to call 911 immediately, then take a second sublingual nitroglycerin tablet as prescribed. Using the time-dependent care and circulation priority framework, persistent chest pain after the first nitroglycerin dose must be treated as possible acute coronary syndrome until proven otherwise. Nitroglycerin dilates veins and coronary arteries, which reduces myocardial oxygen demand and may improve coronary blood flow, but failure of pain to resolve suggests ongoing ischemia. The key clinical warning is chest pain that is not completely relieved within 5 minutes of the first dose. The tempting choice to take another tablet and wait is unsafe because it delays EMS activation and definitive cardiac evaluation.

The correct response is the statement that levothyroxine will be taken in the morning on an empty stomach because food can significantly reduce and delay absorption. This question uses the Nursing Process, specifically evaluation, because the nurse must determine whether medication teaching was understood. Levothyroxine replaces deficient thyroid hormone, supporting metabolic function, energy level, heart rate regulation, and temperature control. A key clinical pearl is that thyroid replacement must be taken consistently and separated from foods, calcium, iron, antacids, and other interacting products that impair absorption. The tempting breakfast-related distractor is wrong because taking the medication with food may lead to inadequate dosing even when the prescribed amount is correct.

The most appropriate action is to slow the IV infusion rate and continue monitoring because the client is showing a mild vancomycin infusion reaction. Using the ABCs, the nurse notes that airway, breathing, and circulation are currently stable, so emergency treatment for anaphylaxis is not indicated. This reaction is caused by non-IgE-mediated histamine release, most often related to rapid vancomycin infusion. The key warning signs that would change the priority are wheezing, stridor, angioedema, hypotension, or respiratory distress. The tempting distractor is to stop the infusion completely and notify the provider, but that is reserved for more severe or unstable findings rather than isolated flushing with stable vital signs.

The nurse should intervene for the high-tyramine processed meat because phenelzine, an MAOI, prevents normal tyramine breakdown. Using a Safety and Risk Reduction framework, the priority is to recognize and remove foods that can cause serious medication-food interactions before harm occurs. Tyramine accumulation can promote a sudden release of norepinephrine, leading to severe hypertension and possible hypertensive crisis. Warning signs include severe headache, palpitations, chest pain, neck stiffness, nausea, vomiting, and marked elevation in blood pressure. Fresh chicken may seem concerning because it is meat, but fresh, properly prepared meat is not the same risk as cured, smoked, aged, or fermented meat.

The client is at immediate risk for ototoxicity, which may cause tinnitus, hearing changes, or hearing loss after rapid IV administration of furosemide. The nurse uses Safety and Risk Reduction by recognizing that the unsafe administration rate creates a medication-related harm. Furosemide is a loop diuretic that inhibits sodium and chloride reabsorption in the loop of Henle, producing strong diuresis but also increasing electrolyte loss and ototoxic risk when given too quickly. A key clinical warning is new ringing in the ears or decreased hearing after IV loop diuretic administration. The most tempting distractor is hyperkalemia, but furosemide wastes potassium and more commonly causes hypokalemia.

The statement about starting a low-sodium diet indicates a need for further teaching because sodium restriction can increase lithium reabsorption and raise serum lithium levels. Using the Nursing Process, the nurse evaluates the client’s understanding and identifies this statement as unsafe. Lithium is handled by the kidneys in a manner similar to sodium; sodium depletion, dehydration, and some medications can reduce lithium clearance and cause toxicity. A key clinical pearl is that clients should maintain consistent fluid and sodium intake and report vomiting, diarrhea, worsening tremor, confusion, or ataxia promptly. Regular serum lithium monitoring is not concerning; it is required because lithium has a narrow therapeutic range.

The priority symptom is unexplained muscle pain and weakness because it can signal statin-associated myopathy and, rarely, rhabdomyolysis. Using the Safety and Risk Reduction framework, the nurse must recognize the adverse effect most likely to cause serious harm and prompt rapid evaluation. Statins lower cholesterol by inhibiting hepatic cholesterol synthesis, but muscle injury can occur; severe muscle breakdown releases myoglobin, which may contribute to acute kidney injury. A key warning sign is new or worsening muscle pain, tenderness, or weakness, especially if accompanied by dark urine, malaise, or fever. Mild gastrointestinal symptoms or a mild headache are more common, nonurgent effects and do not carry the same immediate risk as possible rhabdomyolysis.

The correct answer is 1400 because NPH insulin is an intermediate-acting insulin that typically peaks about 4–12 hours after administration. Using a medication safety and risk-reduction framework, the nurse analyzes the administration time and identifies when the insulin effect will be strongest. During peak insulin action, more glucose is moved from the bloodstream into cells, increasing the risk for hypoglycemia, especially if food intake is delayed or inadequate. A key clinical pearl is to match meals and snacks with insulin peak times and monitor for shakiness, diaphoresis, confusion, tachycardia, or sudden hunger. The most tempting distractor, 1000, is too early for NPH peak action and is more consistent with the expected peak timing of short-acting regular insulin.

The nurse should hold metoprolol and notify the provider when the client has a heart rate of 52 beats/min because this indicates bradycardia. Using a Safety and Risk Reduction approach, the nurse must recognize a medication-related risk before administration and prevent further slowing of the heart rate. Metoprolol is a beta blocker that primarily blocks cardiac beta-1 receptors, decreasing heart rate, atrioventricular conduction, and myocardial contractility. A key clinical pearl is to check the pulse and blood pressure before giving beta blockers and follow ordered or facility holding parameters, commonly holding for pulse below 60 beats/min. The normal blood pressure is a tempting distractor, but it reflects adequate control rather than a reason to withhold the drug when the client is otherwise stable.

The best response is to teach the client that prednisone must be tapered gradually after prolonged high-dose therapy to prevent acute adrenal insufficiency. The clinical reasoning is medication safety: the nurse must identify the unsafe plan, explain the risk, and direct the client to follow the prescribed taper rather than stopping independently. Exogenous corticosteroids suppress the hypothalamic-pituitary-adrenal axis, so abrupt withdrawal can leave the body without enough cortisol during physiologic stress. The critical warning signs of adrenal crisis include severe weakness, nausea, vomiting, hypotension, hypoglycemia, and shock. Switching to an NSAID such as ibuprofen may reduce pain or inflammation in some conditions, but it does not replace cortisol activity or prevent adrenal crisis.